Application of breast cancer risk prediction models in clinical practice.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Clinical Oncology

• Publication date

  2003-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2003.07.007PMID 12586794
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tamoxifen for Prevention of Breast Cancer

  2003cited by this paper
• Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

  2002cited by this paper
• Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

  2002cited by this paper
• Risk management in BRCA1 and BRCA2 mutation carriers: lessons learned, challenges posed.

  2002cited by this paper
• Family history of cancer, oral contraceptive use, and ovarian cancer risk.

  2002cited by this paper
• BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.

  2002cited by this paper
• Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

  2002cited by this paper
• Cancer Incidence in BRCA1 mutation carriers.

  2002cited by this paper
• Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.

  2002cited by this paper
• Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

  2002cited by this paper
• Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.

  2002cited by this paper
• Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.

  2001cited by this paper
• A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

  2001cited by this paper
• Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.

  2001cited by this paper
• Comparisons of two breast cancer risk estimates in women with a family history of breast cancer.

  2001cited by this paper
• Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk.

  2001cited by this paper
• Prevalence of breast cancer predisposition gene mutations in Chinese women and guidelines for genetic testing.

  2001cited by this paper
• Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.

  2001cited by this paper
• A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center

  2000cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer

  2000cited by this paper
• American Cancer Society guidelines for the early detection of cancer

  2000cited by this paper
• Genetic and hormonal risk factors in breast cancer.

  2000cited by this paper
• Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.

  2000cited by this paper
• Frequency of BRCA1/BRCA2 mutations in a population‐based sample of young breast carcinoma cases

  2000cited by this paper
• Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer

  2000cited by this paper
• BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers.

  2000cited by this paper
• The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group.

  2000cited by this paper
• The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives

  2000cited by this paper
• The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.

  1999cited by this paper
• Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.

  1999cited by this paper
• Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.

  1999cited by this paper
• Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

  1999cited by this paper
• Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer.

  1999cited by this paper
• Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.

  1999cited by this paper
• Cancer risks in BRCA2 mutation carriers.

  1999cited by this paper
• BRCA1 mutations in African Americans

  1999cited by this paper
• Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors.

  1998cited by this paper
• Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.

  1998cited by this paper
• Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.

  1998cited by this paper
• Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.

  1998cited by this paper
• Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes.

  1998cited by this paper
• BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing.

  1998cited by this paper
• Oral Contraceptives and the Risk of Hereditary Ovarian Cancer

  1998cited by this paper
• Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

  1998cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients.

  1998cited by this paper
• Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

  1997cited by this paper
• The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

  1997cited by this paper
• BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

  1997cited by this paper
• Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases

  1997cited by this paper
• Contribution of BRCA1 mutations to ovarian cancer.

  1997cited by this paper
• High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history.

  1997cited by this paper
• BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.

  1997cited by this paper
• Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.

  1997cited by this paper
• The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.

  1997cited by this paper
• BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

  1997cited by this paper
• Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.

  1997cited by this paper
• Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population.

  1997cited by this paper
• Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.

  1997cited by this paper
• Agreement between breast cancer risk estimation methods.

  1996cited by this paper
• BRCA1 mutations in young women with breast cancer.

  1996cited by this paper
• BRCA2 germline mutations in male breast cancer cases and breast cancer families

  1996cited by this paper
• Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

  1996cited by this paper
• The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

  1996cited by this paper
• Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.

  1996cited by this paper
• Teratogenicity of high vitamin A intake.

  1996cited by this paper
• Breast cancer and BRCA1 mutations.

  1996cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Unusual case of Smith-Lemli-Opitz syndrome "type II".

  1995cited by this paper
• Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence.

  1995cited by this paper
• Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction

  1994cited by this paper
• Quantitating familial cancer risk: a resource for clinical oncologists.

  1994cited by this paper
• The calculation of breast cancer risk for women with a first degree family history of ovarian cancer

  1993cited by this paper
• A prospective study of benign breast disease and the risk of breast cancer

  1992cited by this paper
• Family history and risk of breast cancer.

  1992cited by this paper
• Genetic analysis of breast cancer in the cancer and steroid hormone study.

  1991cited by this paper
• Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

  1989cited by this paper
• Risk factors for breast cancer in women with proliferative breast disease.

  1985cited by this paper
• Risk of familial breast cancer

  1985cited by this paper
• Family history and the risk of breast cancer.

  1985cited by this paper
• Practical guide for estimating risk for familial breast cancer.

  1983cited by this paper
• Lobular neoplasia (so‐called lobular carcinoma in situ) of the breast

  1978cited by this paper
• Lobular carcinoma in situ of the breast Detailed analysis of 99 patients with average follow‐up of 24 years

  1978cited by this paper

• What are the Key Components of an Advanced Nurse Practitioner (ANP) Led High-Risk Family History Breast Clinic? A Scoping Review.

  2025cites this paper
• Ultrasonographic BI-RADS 4 Lesions Related to Breast Cancer Risk Factors

  2025cites this paper
• Critical Risk Assessment, Diagnosis, and Survival Analysis of Breast Cancer

  2024cites this paper
• Spatiotemporal Mammography-based Deep Learning Model for Improved Breast Cancer Risk Prediction

  2023cites this paper
• Comparing risk prediction models aimed at predicting hospitalizations for adverse drug events in community dwelling older adults: a protocol paper

  2023cites this paper
• Methodological Issues with Head and Neck Cancer Prognostic Risk Prediction Models

  2023cites this paper
• A Practical Approach to Disease Risk Prediction: Focus on High-Risk Patients via Highest-k Loss

  2023cites this paper
• Breast cancer risk stratification using genetic and non-genetic risk assessment tools for 246,142 women in the UK Biobank.

  2023cites this paper
• An app to classify a 5-year survival in patients with breast cancer using the convolutional neural networks (CNN) in Microsoft Excel

  2022cites this paper
• Bilateral Analysis Boosts the Performance of Mammography-based Deep Learning Models in Breast Cancer Risk Prediction

  2022cites this paper
• Real-World Implementation of Precision Psychiatry: A Systematic Review of Barriers and Facilitators

  2022cites this paper
• Utilization of breast cancer risk prediction models by cancer genetic counselors in clinical practice predominantly in the United States

  2021cites this paper
• Applications of Machine Learning in Disease Pre-screening

  2021cites this paper
• Reproductive, Lifestyle, and Genetic Risk Factors in Breast Cancer Among Iranian Women- A Cross-sectional Study During the Breast Cancer Screening in a Community in Iran

  2020cites this paper
• Finding discriminatory features from electronic health records for depression prediction

  2020cites this paper
• Cancer of the Breast

  2020cites this paper
• Application of artificial intelligence and machine learning for prediction of oral cancer risk.

  2020cites this paper
• Adjuvant treatment of early male breast cancer

  2020cites this paper
• Applications of Machine Learning in Cancer Prediction and Prognosis

  2020cites this paper
• Image Segmentation and the Projections of Graphic Centred Approaches in Medical Image Processing

  2020cites this paper
• Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study

  2020cites this paper
• Potential of using mammography screening appointments to identify high-risk women: cross sectional survey results from the national health interview survey

  2020cites this paper
• Hereditary Risk for Cancer

  2019cites this paper
• Performance of the Gail and Tyrer-Cuzick breast cancer risk assessment models in women screened in a primary care setting with the FHS-7 questionnaire

  2019cites this paper
• Automated analysis of breast MRI: From Traditional Methods into Deep Learning

  2019cites this paper
• Importance of family history and indications for genetic testing

  2019cites this paper
• Breast cancer mortality in Chinese women: does migrant status play a role?

  2019cites this paper
• Series WP-1 9-0 5 Meta-Analysis for Medical Decisions

  2019influential citation
• Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program

  2019cites this paper
• Disease Risk Models

  2019cites this paper
• BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance

  2019cites this paper
• A feasibility study of breast cancer genetic risk assessment in a federally qualified health center

  2018cites this paper
• Breast MRI for screening: evaluation of clinical practice and future perspectives

  2018cites this paper
• The Pink Underside: The Commercialization of Medical Risk Assessment and Decision-Making Tools for Hereditary Breast Cancer Risk

  2018cites this paper
• Risk prediction models for familial breast cancer

  2018cites this paper
• Bayesian estimation of a semiparametric recurrent event model with applications to the penetrance estimation of multiple primary cancers in Li-Fraumeni syndrome.

  2018cites this paper
• Fluoxetine After Weight Restoration in Anorexia Nervosa

  2017cites this paper
• Statistical Methods for Two Problems in Cancer Research: Analysis of RNA-seq Data from Archival Samples and Characterization of Onset of Multiple Primary Cancers

  2017cites this paper
• A case-control study on risk factors of breast cancer in Han Chinese women

  2017cites this paper
• Data Mining of the Human Being

  2017cites this paper
• Breast density quantification using structured-light-based diffuse optical tomography simulations.

  2017cites this paper
• Bayesian Artificial Neural Networks in Health and Cybersecurity

  2017cites this paper
• Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil

  2016cites this paper
• Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer

  2016cites this paper
• Predictive modeling of hospital readmissions using metaheuristics and data mining

  2015cites this paper
• Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.

  2015cites this paper
• The knowledge value-chain of genetic counseling for breast cancer: an empirical assessment of prediction and communication processes

  2015cites this paper
• Performance of the Gail Model for Breast Cancer Risk Assessment in Iranian Women

  2015cites this paper
• Improving accuracy of genomic prediction by genetic architecture based priors in a Bayesian model

  2015cites this paper
• M-SEQ: Early detection of anxiety and depression via temporal orders of diagnoses in electronic health data

  2015cites this paper
• Breast cancer in China.

  2014cites this paper
• A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population

  2014cites this paper
• Machine learning applications in cancer prognosis and prediction

  2014cites this paper
• Breast cancer screening in an era of personalized regimens: A conceptual model and National Cancer Institute initiative for risk‐based and preference‐based approaches at a population level

  2014cites this paper
• Risk assessment, genetic counseling, and clinical care for hereditary breast cancer.

  2014cites this paper
• Biomedical Informatics for Cancer Research

  2014cites this paper
• RNAi Screening of the Kinome to Identify Mediators of proliferation and trastuzumab (Herceptin) resistance in HER2 Breast Cancers

  2013cites this paper
• Predicting risk: developing and testing of a nomogram to predict hospitalisation in chronic heart failure (CHF- Risk Study)

  2013cites this paper
• Management of Genetic Syndromes Predisposing to Gynecologic Cancers

  2013cites this paper
• Risk Factors for Breast Cancer Among Chinese Women: A 10-Year Nationwide Multicenter Cross-Sectional Study

  2013cites this paper
• Results from a randomized trial of a web-based, tailored decision aid for women at high risk for breast cancer.

  2013cites this paper
• Risk assessment for breast cancer and BRCA mutations in women with personal and familial history

  2013cites this paper
• An overview of risk prediction models and the implications for nursing practice

  2012cites this paper
• Genetic Polymorphisms as Predictors of Breast Cancer Risk

  2012cites this paper
• Low Rates of African American Participation in Genetic Counseling and Testing for BRCA1/2 Mutations: Racial Disparities or Just a Difference?

  2012cites this paper
• Understanding The Beliefs of Ashkenazi Jewish Individuals Regarding Cancer Genetic Counseling Services

  2012cites this paper
• AACR Cancer Progress Report 2012

  2012cites this paper
• A Clinical Risk Prediction Model for Barrett Esophagus

  2012cites this paper
• Best Practice & Research Clinical Obstetrics and Gynaecology

  2012cites this paper
• Screening for gynaecologic cancers in genetically predisposed women.

  2012cites this paper
• Individual Breast Cancer Risk Assessment in Underserved Populations: Integrating Empirical Bioethics and Health Disparities Research

  2012cites this paper
• Prediction, Communication, and Distribution of Breast Cancer Risk

  2012cites this paper
• A case-control study on risk factors of breast cancer in China

  2012cites this paper
• "Getting on with it": New Zealand Women's Experiences of Living with an Increased Risk of Breast and Ovarian Cancer

  2011cites this paper
• Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer

  2011cites this paper
• Estimated risk of invasive breast cancer in postmenopausal women with and without family history of the disease

  2011cites this paper
• Hereditary Breast Cancer Syndromes

  2011cites this paper
• [A new scoring system for the diagnosis of BRCA1/2 associated breast-ovarian cancer predisposition].

  2011cites this paper
• An Extensive Survey on Artificial neural Network Based Cancer Prediction Using Soft-Computing Approach

  2011cites this paper
• Metaanaliza penetracji BRCA1 i BRCA2

  2011cites this paper
• HER receptor-mediated dynamic signalling in breast cancer cells

  2011cites this paper
• Familial and genetic cancers in gynaecology

  2010cites this paper
• The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers

  2010cites this paper
• Five-Year and Lifetime Risk of Breast Cancer among U.S. Subpopulations: Implications for Magnetic Resonance Imaging Screening

  2010cites this paper
• Inherited Cancer Syndromes

  2010cites this paper
• Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions

  2010cites this paper
• Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information

  2010cites this paper
• Effect of Genetic Counseling and Testing for BRCA1 and BRCA2 Mutations in African American Women: A Randomized Trial

  2010cites this paper
• Assessing women at high risk of breast cancer: a review of risk assessment models.

  2010cites this paper
• Screening criteria for breast cancer.

  2010cites this paper
• The application of genetics and genomics to cancer prevention.

  2010cites this paper
• Breast Cancer Prevention: Patient Decision Making and Risk Communication in the High Risk Setting

  2010cites this paper
• Title Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions

  2010cites this paper
• Familial Cancer Risk Assessment Using BayesMendel

  2010cites this paper
• The Effect of BRCA Gene Testing on Family Relationships: A Thematic Analysis of Qualitative Interviews

  2009cites this paper
• Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern Brazil

  2009cites this paper
• Consistency of self-reported first-degree family history of cancer in a population-based study

  2009cites this paper
• Utilization of Religious Coping Strategies Among African American Women at Increased Risk for Hereditary Breast and Ovarian Cancer

  2009cites this paper
• Diffusion of Breast Cancer Risk Assessment in Primary Care

  2009cites this paper
• Establishing a Family Risk Assessment Clinic for Breast Cancer

  2009cites this paper